Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 10 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ACTUATE THERAPEUTICS, INC. | 2,506,667 | reported | 14 Aug 2024 | tx 56+9,933,650−9,443,649 |
| IN8BIO, INC. | 1,283,281 | reported | 04 Oct 2024 | tx 10+2,617,776 |
| Lantern Pharma Inc. | 114,272 | reported | 13 Jun 2025 | tx 5−40,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 13 Jun 2025 | SALE | Lantern Pharma Inc. | 12,319 | 3.09 USD | |
| 13 Jun 2025 | SALE | Lantern Pharma Inc. | 4,354 | 3.09 USD | |
| 13 Jun 2025 | SALE | Lantern Pharma Inc. | 1,903 | 3.09 USD | |
| 13 Jun 2025 | SALE | Lantern Pharma Inc. | 14,218 | 3.09 USD | |
| 13 Jun 2025 | SALE | Lantern Pharma Inc. | 7,206 | 3.09 USD | |
| 04 Oct 2024 | OTHER | IN8BIO, INC. | 574,241 | — | deriv |
| 04 Oct 2024 | GRANT_AWARD | IN8BIO, INC. | 574,241 | — | deriv |
| 04 Oct 2024 | PURCHASE | IN8BIO, INC. | 709,040 | — | deriv |
| 04 Oct 2024 | PURCHASE | IN8BIO, INC. | 709,040 | — | deriv |
| 14 Aug 2024 | CONVERSION | ACTUATE THERAPEUTICS, INC. | 153,702 | — | |
| 14 Aug 2024 | CONVERSION | ACTUATE THERAPEUTICS, INC. | 54,032 | — | |
| 14 Aug 2024 | CONVERSION | ACTUATE THERAPEUTICS, INC. | 176,499 | — | |
| 14 Aug 2024 | CONVERSION | ACTUATE THERAPEUTICS, INC. | 23,628 | — | |
| 14 Aug 2024 | CONVERSION | ACTUATE THERAPEUTICS, INC. | 147,047 | — | |
| 14 Aug 2024 | CONVERSION | ACTUATE THERAPEUTICS, INC. | 101,900 | — | |
| 14 Aug 2024 | CONVERSION | ACTUATE THERAPEUTICS, INC. | 332,867 | — | |
| 14 Aug 2024 | CONVERSION | ACTUATE THERAPEUTICS, INC. | 44,559 | — | |
| 14 Aug 2024 | CONVERSION | ACTUATE THERAPEUTICS, INC. | 309,589 | — | |
| 14 Aug 2024 | CONVERSION | ACTUATE THERAPEUTICS, INC. | 2,022,029 | — | |
| 14 Aug 2024 | CONVERSION | ACTUATE THERAPEUTICS, INC. | 326,547 | — | |
| 14 Aug 2024 | CONVERSION | ACTUATE THERAPEUTICS, INC. | 2,094,650 | — | |
| 14 Aug 2024 | CONVERSION | ACTUATE THERAPEUTICS, INC. | 74,202 | — | |
| 14 Aug 2024 | CONVERSION | ACTUATE THERAPEUTICS, INC. | 484,638 | — | |
| 14 Aug 2024 | CONVERSION | ACTUATE THERAPEUTICS, INC. | 78,267 | — | |
| 14 Aug 2024 | CONVERSION | ACTUATE THERAPEUTICS, INC. | 573,394 | — |
1 purchase reported after at least 12 months of silence — most recent on 14 Aug 2024.